For patients with psoriasis concerned about their outcome if infected with COVID-19, “there is no evidence to support stopping biologics or systemic agents.”
The conference abstracts covered many topics including psoriasis, psoriatic arthritis, and atopic dermatitis. They were published with Seminars in Cutaneous Medicine & Surgery (scmsjournal.com).
Abstracts presented this annual meeting featuring psoriasis, atopic dermatitis, rosacea, actinic keratosis, nail disease, psoriatic arthritis and more.
